Latest news with #longcovid
RNZ News
16 hours ago
- Health
- RNZ News
Approaching life-changing diagnosis for "missing millions" with ME/CFS
Photo: Professor Warren Tate Photo: Supplied Anyone who has or knows someone with ME, chronic syndrome fatigue or long covid knows that being believed is one of the toughest parts of having the condition. University of Otago Emeritus Professor Warren Tate has dedicated his life to researching ME/CFS and is considered a leading authority on long covid. Along with his team, he has been developing a diagnostic test, that so far has shown promising results. If implemented, it would be life-changing. Warren and his co-researcher Dr Katie Peppercorn have also released a one-of-a-kind book to help clinicians and researchers find ways of better understanding post-viral conditions and improve the lives of those 'missing millions' affected with ME/CFS and most recently long covid.
RNZ News
16 hours ago
- Health
- RNZ News
Approaching life-changing diagnosis for 'missing millions'
Photo: Professor Warren Tate Photo: Supplied Anyone who has or knows someone with ME, chronic syndrome fatigue or long covid knows that being believed is one of the toughest parts of having the condition. University of Otago Emeritus Professor Warren Tate has dedicated his life to researching ME/CFS and is considered a leading authority on long covid. Along with his team, he has been developing a diagnostic test, that so far has shown promising results. If implemented, it would be life-changing. Warren and his co-researcher Dr Katie Peppercorn have also released a one-of-a-kind book to help clinicians and researchers find ways of better understanding post-viral conditions and improve the lives of those 'missing millions' affected with ME/CFS and most recently long covid.
Washington Post
16-05-2025
- Health
- Washington Post
Long covid patients are desperate for treatments. These trials may help.
Five years since the pandemic began, millions of people are still grappling with long covid, even as new patients are joining their ranks. 'Considering how far along we are and how tens of millions of people are suffering, we've done very little,' said Eric Topol, a professor of translational medicine and the executive vice president of Scripps Research.
